Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 85-89

  Cavallaro, A M ^a   Lilleby, K ^b   Majolino, I ^a   Storb, R ^b   Appelbaum, F R ^b   Rowley, S D ^b   Bensinger, W I ^b  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allogeneic stem cells; Filgrastim; G CSF; Normal donors

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; APHERESIS; ARTICLE; BLOOD CELL COUNT; BREAST CANCER; CANCER; CHILDBIRTH; FEMALE; FOLLOW UP; GRANULOCYTE; GRAVES DISEASE; HEART INFARCTION; HEMATOCRIT; HEPATITIS C; HUMAN; HYPERTENSION; LYMPHADENOPATHY; LYMPHOCYTE; MALE; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; SCHOOL CHILD; SIDE EFFECT; SINUSITIS; SPONTANEOUS ABORTION; STEM CELL TRANSPLANTATION; STROKE; THROMBOCYTE COUNT;

EID: 0033979660     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702072     Document Type: Article

References (33)

1. McCredie KB, Hersh EM, Freireich EJ. Cells capable of colony formation in the peripheral blood of man. Science 1971; 171: 293-294.
2. Socinski MA, Cannistra SA, Elias A et al. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; i: 1194-1198.
3. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82; 1981-1984.
4. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow tor allogeneic transplantation. Lancet 1993; 341: 1482-1483.
5. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
6. Anderlini P, Przepiorka D, Seong D et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996; 36: 590-595.
7. Majolino I, Cavallero AM, Bacigalupo A et al. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italina bone Marrow Transplantation Group (GITMO). Haematologica 1997; 82: 47-52.
8. Sukamaki S, Matsunaga T, Hirayama Y et al. Haematological study of healthy volunteers 5 years after G-CSF (reply letter). Lancet 1995; 346: 1432-1433.
9. Miflin G, Charley C, Stainer C et al. Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 1996; 95: 345-348.
10. Stroneck DF, Clay ME, Herr G et al. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results ot a second mobilization and collection. Transfusion 1997; 37: 304-308.
11. Bensinger WI, Deeg HJ. Transfusion support and donor considerations in marrow transplantation. In: Sacher RA, AuBuchon JP (eds). Marrow Transplantation: Practical and Technical Aspects of Stem Cell Reconstitution. American Association of Blood Banks: Bethesda, 1992, pp 157-184.
12. Bortin MM, Buckner CD. Major complications of marrow harvesting for transplantation. Exp Hematol 1983; 11: 916-921.
13. Buckner CD, Clift RA, Sanders JE et al. Marrow harvesting from normal donors. Blood 1984; 64: 630-634.
14. Stroncek DF, Holland PV, Bartch G et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 1993; 81: 1940-1946.
15. Parkkali T, Volin L, Sirèn MK et al. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor (case report). Bone Marrow Transplant 1996; 17: 4.33-134.
16. Huhn RD, Yurkow EJ, Tushinski R et al. Recombinant human interleukin-3 (rhlL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol 1996; 24: 839-847.
17. Becker PS, Wagle M, Matous S et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3: 45-49.
18. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407.
19. Fossa SD, Poulsen JP, Aaserud A. Alkaline phosphatase and laclate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer. Lancet 1992; 340: 1544.
20. Russell N, Gratwohl A, Schmitz N. The place of blood stem cells in allogeneic transplantation (annotation). Br J Haematol 1996; 93: 747-753.
21. Anderlini P, Körbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors (editorial). Blood 1997; 90: 903-908.
22. Wedlock ES, Kaplan DL, Cecchini M et al. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood 1993; 81: 916-922.
23. Welte K, Boxer LA. Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol 1997; 34: 267-278.
24. Falanga A, Marchetti M, Oldani E et al. Changes of meostatic parameters in health donors administered G-CSF for peripheral blood progenitor cell (PBPC) collection. Bone Marrow Transplant 1996; 17 (Suppl.): S72.
25. Lowenberg B, Touw IP. Hematopoietic growth factors their receptors in acute leukemia (review). Blood 1993; 81: 281-292.
26. Avalos BR, Gasson JC, Hedvat C et al. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 1990; 75: 851-857.
27. Tachibana M, Miyakawa A, Uchida A et al. Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder. Br J Cancer 1997; 75: 1489-1496.
28. Heil G, Hoelzer D, Sanz MA et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood 1997; 90: 4710-4718.
29. Moore JO, Dodge RK, Amrein PC et al. Granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. Blood 1987; 89: 780-788.
30. Freedman MH. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol 1997; 4: 217-224.
31. Ohara A, Kojima S, Hamajima N et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997; 90: 1009-1013.
32. Parker SL, Tong T, Bolden S et al. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
33. Hasle H, Olsen JH. Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia. Br J Haematol 1997; 97: 127-131.